Pharsight

TRANSLATE BIO PATENTS FACING OPPOSITIONS

Top patents of TRANSLATE BIO facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2970456B1 19 May, 2021 Methods And Compositions For Delivering Mrna Coded Antibodies Mar, 2034 4
EP3336082B1 15 Apr, 2020 Cleavable Lipids Jun, 2032 2
EP3134506B1 07 Aug, 2019 Methods For Purification Of Messenger Rna NA 2
EP3318248B1 10 Apr, 2019 Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases NA 2
EP2506857B1 14 Feb, 2018 Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases NA 2
EP3501605 MRNA-THERAPIE FR ARGININOSUCCI- NAT-SYNTHASE-MANGEL MRNA THERAPY FOR ARGININOSUCCI- NATE SYNTHETASE DEFICIENCY THRAPIE ARNM POUR DFICIENCE EN ARGININOSUCCINATE SYNTHTASE NA 1
EP3060303B1 14 Nov, 2018 Mrna Therapy For Argininosuccinate Synthetase Deficiency Oct, 2034 1
EP3122878B1 24 Oct, 2018 Mrna Therapy For The Treatment Of Ocular Diseases NA 1